Envision Healthcare (EVHC) Given a $50.00 Price Target by Robert W. Baird Analysts

Robert W. Baird set a $50.00 target price on Envision Healthcare (NYSE:EVHC) in a report published on Wednesday, April 11th. The firm currently has a buy rating on the stock.

Several other research analysts also recently issued reports on the stock. Jefferies Group set a $46.00 price objective on shares of Envision Healthcare and gave the stock a buy rating in a research report on Wednesday, April 11th. ValuEngine downgraded shares of Envision Healthcare from a hold rating to a sell rating in a research report on Monday, April 2nd. Mizuho set a $38.00 price objective on shares of Envision Healthcare and gave the stock a hold rating in a research report on Friday, March 2nd. Royal Bank of Canada reaffirmed a buy rating and issued a $48.00 target price on shares of Envision Healthcare in a report on Thursday, March 1st. Finally, SunTrust Banks lifted their target price on shares of Envision Healthcare to $45.00 and gave the company a buy rating in a report on Thursday, March 1st. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $42.57.

How to Become a New Pot Stock Millionaire

Shares of NYSE:EVHC opened at $37.41 on Wednesday. Envision Healthcare has a 12 month low of $23.77 and a 12 month high of $64.00. The company has a current ratio of 3.40, a quick ratio of 3.38 and a debt-to-equity ratio of 0.87. The firm has a market cap of $4,523.80, a P/E ratio of 13.86, a P/E/G ratio of 0.86 and a beta of 0.42.



Envision Healthcare (NYSE:EVHC) last announced its quarterly earnings results on Tuesday, February 27th. The company reported $0.59 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.45 by $0.14. Envision Healthcare had a negative net margin of 2.52% and a positive return on equity of 4.62%. The firm had revenue of $2 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same period last year, the business earned $1.15 EPS. Envision Healthcare’s revenue for the quarter was up 68.0% compared to the same quarter last year. equities analysts expect that Envision Healthcare will post 3.34 EPS for the current fiscal year.

A number of hedge funds have recently added to or reduced their stakes in EVHC. CIBC World Markets Inc. purchased a new stake in Envision Healthcare during the fourth quarter worth about $208,000. OLD Mutual Customised Solutions Proprietary Ltd. boosted its holdings in Envision Healthcare by 88.2% during the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 6,401 shares of the company’s stock worth $221,000 after buying an additional 3,000 shares in the last quarter. CENTRAL TRUST Co boosted its holdings in Envision Healthcare by 79.7% during the fourth quarter. CENTRAL TRUST Co now owns 6,626 shares of the company’s stock worth $229,000 after buying an additional 2,939 shares in the last quarter. Alps Advisors Inc. purchased a new stake in Envision Healthcare during the fourth quarter worth about $235,000. Finally, M&T Bank Corp boosted its holdings in Envision Healthcare by 33.6% during the fourth quarter. M&T Bank Corp now owns 6,818 shares of the company’s stock worth $235,000 after buying an additional 1,716 shares in the last quarter.

COPYRIGHT VIOLATION WARNING: This news story was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://stocknewstimes.com/2018/04/22/robert-w-baird-reiterates-50-00-price-target-for-envision-healthcare-evhc.html.

About Envision Healthcare

Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.

Analyst Recommendations for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply